Prischak, Sara

Real-world evidence for pembrolizumab gemcitabine vinorelbine and liposomal doxorubicin in classical Hodgkin lymphoma

Baek, Grace , Varma, Gaurav, Yamshon, Samuel , Besien, Herman J van, Bartlett, Nancy L., Watkins, Marcus P. , Baron, K., Falade, Ayo , Svoboda, Jakub, Prischak, Sara, D'Angelo, C., Lukowski, Joe D., Advani, Ranjana H, Yeung, Austin, Rosenberg, Maya, Lynch, Ryan C. , Poh, Christina, Raghunathan, Vikram, Shadman, Mazyar, Smith, Stephen D. , Ujjani, Chaitra S., Bartlett, Nancy L. , Advani, Ranjana H. , Varma, Gaurav , Baron, Margaret Kelsey , van Besien, Herman , Bartlett, Nancy L , Watkins, Marcus , Baron, Kelsey , Falade, Ayo S , Prischak, Sara , D'Angelo, Christopher , Lukowski, Joe D , Di, Mengyang , Lynch, Ryan C , Poh, Christina , Shadman, Mazyar , Smith, Stephen D , Ujjani, Chaitra , Diefenbach, Catherine S , Advani, Ranjana H , Shah, Harsh R., Merryman, Reid W. , Svoboda, Jakub , Voutsinas, Jenna M. , Di, Mengyang , Raghunathan, Vikram M. , Shadman, Mazyar , Till, Brian G. , Ujjani, Chaitra S. , Diefenbach, Catherine , Gopal, Ajay K.

Blood Advances | March 19, 2026 | Volume: 10 | Issue: 10 | Pages: 3565-3571

10.1182/bloodadvances.2025018267